Introduction {#s1}
============

Mammalian oocytes and early preimplantation embryos are surrounded by a glycoprotein shell termed zona pellucida (ZP) that serves important functions during folliculogenesis, species-specific fertilization and early development. In eutherian mammals, this glycoprotein shell is solely composed of 3 to 4 proteins depending on the species. The differences in ZP composition between eutherian mammals is the consequence of duplication and/or pseudogenization events during evolution. In all eutherian mammals studied so far ZP always contain ZP2 and ZP3 proteins, but ZP1 or ZP4 may be absent, as both are paralogous genes formed by duplication of a common ancestry gene (reviewed by [@bib10]).

The functions of the three proteins (ZP1, ZP2 and ZP3) present in mouse ZP have been elucidated by gene ablation experiments. ZP1 serves a structural function, being dispensable for sperm binding or fertilization ([@bib34]). ZP1 null females display perturbed folliculogenesis and, although ovulation rates are not affected, both cleavage rate and litter size are reduced, likely due to ZP1-null zona being unable to protect the developing embryo. ZP2 ablation also results in structural defects, which are more severe, as the number of antral follicles is reduced and only few ZP-free oocytes and no two-cell embryos are recovered from *Zp2* knock-out (KO) females after mating ([@bib35]). Finally, *Zp3* KO mice are unable to form ZP, showing a drastic reduction in ovulation rates and also being unable to produce cleaved embryos after mating ([@bib22]; [@bib33]). Given the lack of ZP on ovulated *Zp2-* or *Zp3*-null oocytes, these KO models could not assess the role of these proteins on sperm binding. To study that process, more complex gain-of-function transgenic mouse models have been generated. In particular, the generation of ZP composed of different combinations of human ZP proteins ([@bib2]) or an heterologous ZP lacking mouse ZP2 protein ([@bib1]) have uncovered a crucial role of ZP2 on mouse and human sperm recognition.

The fourth ZP protein component, ZP4, is absent in mice, which seems to be an exception for mammals, as ZP4 is present in multiple mammalian species including humans ([@bib15]; [@bib20]), rabbits ([@bib40]), ungulates ([@bib12]; [@bib28]; [@bib43]), carnivores ([@bib26]) and other rodents ([@bib14]; [@bib16]). The lack of ZP4 in laboratory mouse (*Mus musculus*), the only species where KO models were readily available, has precluded the study of the role of this protein by of loss-of-function experiments. Gene ablation experiments are essential to unequivocally know the function of a gene, but were largely restricted to mice, given the technical difficulties to perform site-specific genome modification in other mammalian species ([@bib19]). Luckily, the advent of site-specific endonucleases, and particularly CRISPR, the last technology to be developed and the easiest to tailor to its genomic target, allows direct KO generation in one step. Using this technology, we have generated *ZP4*-null rabbits uncovering that ZP4 confers structural properties to the ZP that are essential to protect the developing preimplantation embryo.

Results {#s2}
=======

Generation of *ZP4* KO rabbits {#s2-1}
------------------------------

*ZP4* gene ablation was achieved by CRISPR-mediated mutagenesis at the zygote stage. For this aim, a sgRNA targeting the beginning of *ZP4* coding region was designed ([Figure 1A](#fig1){ref-type="fig"}). Cas9-coding capped polyadenylated mRNA and *ZP4*-targeting sgRNA were injected into the ooplasm at 100 and 25 ng/µl, respectively. Following microinjection, 50 embryos were transferred to the oviduct of two pseudopregnant recipients (20 and 30 embryos/female), resulting in the delivery of 12 pups (5 and 7, respectively). Genotyping was performed on ear biopsies and blood samples from each pup. Genome edition rates were assessed by sequencing a PCR product containing the target site. This initial screening revealed that all 12 pups were edited at the target site, but it did not allow to identify each mutated allele harbored by each individual. For this aim, clonal sequencing was performed, revealing that all pups but one male were mosaic, that is contained more than two alleles. This phenomenon appears when DNA replication precedes genome edition and has been commonly observed following zygote microinjection in different mammalian species ([@bib19]), including rabbits ([@bib11]; [@bib13]; [@bib23]; [@bib38]; [@bib39]; [@bib41]; [@bib44]; [@bib46]; [@bib49]), where genome replication takes place shortly after fertilization ([@bib29]; [@bib42]).

![Generation of *ZP4* KO rabbits.\
(**A**) A sgRNA was designed for a genomic target located at the beginning of the coding region. Upper sequence depicts wild-type sequence with the start codon underlined and CRISPR target sequence marked in bold letters. Examples of different indels obtained in F0 generation are depicted below. Both in-frame indels (i.e., multiple of three) and frame-disrupting (i.e., not multiple of three) were obtained. Only frame disrupting indels generate truly KO alleles by disrupting the ORF of *ZP4*. The KO allele involving a G insertion was selected to establish a line. (**B**) Wild-type and *ZP4*-null cumulus oocyte complexes following immunohistochemistry with an anti-ZP4 antibody.](elife-48904-fig1){#fig1}

In the absence of an homologous recombination template, CRISPR-mediated gene ablation relies on the generation of frame-disrupting insertion-deletions (indels) by non-homologous end joining (NHEJ) ([@bib19]). As some of the indels generated do not alter the Open Reading Frame of the gene, only those individuals harboring frame-disrupting mutations in all alleles can be considered KO. None of the seven females generated in F0 were KO, as all contained at least one in-frame indel ([Figure 1A](#fig1){ref-type="fig"}). This situation precluded the use of F0 generation for direct experimentation. Consequently, founders were breed to obtain wild-type (WT), heterozygous (Hz) or knock-out (KO) females in subsequent generations. A non-mosaic male containing two frame-disrupting indels was able to breed normally, as expected, given that ZP4 protein is exclusively expressed in ovaries. This male was crossed to mosaic females to generate KO animals (i.e., harboring two frame-disrupting indels) that were used for an initial fertility (pregnancy) screening. Subsequently, one of the KO alleles carried by that male and formed by a G insertion was selected in Hz (WT/KO) animals to maintain the line and generate WT, Hz and KO individuals for experiments. Off-target analysis revealed no genome edition in any of the five most probable off-target sites ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Protein ablation in KO female individuals was confirmed by IHC in ovaries ([Figure 1B](#fig1){ref-type="fig"}). Proteomics analysis of solubilized extracts of ZP from oocytes obtained from KO and WT individuals by tandem mass spectrometry further confirmed the absence of ZP4 in KO individuals. *ZP4* ablation did not prevent the synthesis of all other three rabbit ZP proteins (ZP1-3), which were also detected in the solubilized extract of *ZP4* KO ZP ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). This analysis also provides a semi-quantitative estimation of the amount of ZP1-3 proteins based on the number of peptides detected for each protein, which were similar for KO and WT oocytes, thereby suggesting that ZP4 ablation does not induce major alterations in ZP1-3 synthesis.

ZP4 ablation leads to severely impaired fertility {#s2-2}
-------------------------------------------------

The effect of *ZP4* ablation on female fertility was initially tested by crossing WT, Hz or KO females with fertile WT males. WT and Hz females delivered normal litter sizes, whereas only one out of 10 KO females, delivered a single litter of reduced size (four pups, [Figure 2A](#fig2){ref-type="fig"}). In order to elucidate the root for the reproductive failure caused by *ZP4* ablation, ovulation and embryonic cleavage rates were assessed in WT, Hz or KO females. For this aim, five females per group were crossed with WT males and sacrificed 15 hr after mating. Ovulation rates following natural mating were similar between all groups, suggesting that *ZP4* ablation did not impair folliculogenesis ([Figure 2B](#fig2){ref-type="fig"}). To further test the normalcy of *ZP4*-null follicles, a histological analysis was performed on KO or WT ovaries. *ZP4* disrupted ovaries were grossly indistinguishable from WT or Hz and no obvious abnormalities were noted in follicular population ([Figure 2E--H](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

![ZP4 ablation leads to severely impaired fertility.\
(**A**) Number of pups delivered in WT, Hz and KO females. *ZP4* ablation significantly impaired fertility: only one female out of 10 delivered a small litter of 4 pups, whereas *ZP4* haploinsufficiency (Hz) did not affect fertility. (**B--G**) *ZP4* disruption did not affect ovulation (**B**), cleavage (**C**) and blastocyst (**D**) rates, preantral (**E**) and antral (**F**) follicles counts or pronuclei formation rate (**G**). The number of females (**A--B**), embryos (C-D and G) and slides (**E--F**) analysed per group is indicated inside each column. Data are represented as mean ± SEM in all graphs. Statistical differences are based on ANOVA (p\<0.05, (**A--D**) or t-test (p\<0.05, (**E--F**). (**H**) Representative images of zygotes obtained from WT or KO females showing normal pronuclear formation (SYTOX green staining) in the presence (WT) or absence (KO) of ZP4 in ZP.](elife-48904-fig2){#fig2}

To analyse embryonic cleavage rates, presumptive zygotes were obtained by oviductal flushing and subsequently cultured in vitro. Cleavage rates did not differ between the different groups, suggesting that ZP4 does not play an essential role in fertilization in vivo ([Figure 2C](#fig2){ref-type="fig"}). Cleaved embryos were allowed to develop to the blastocyst stage in vitro. Again, no differences were noted in blastocyst rates or morphology, showing that embryos derived from *ZP4*-null oocytes (Hz embryos enclosed by a ZP4-null ZP, MATKO embryos) are able to reach the blastocyst stage in vitro ([Figure 2D](#fig2){ref-type="fig"}). To further confirm that spermatozoa were able to penetrate through the *ZP4*-disrupted zona, pronuclei formation was assessed in zygotes collected from KO and WT (three animals per group). Normal pronuclear formation was noted for embryos derived from *ZP4*-null oocytes, showing no effect of *ZP4* ablation on the in vivo fertilization process ([Figure 2G](#fig2){ref-type="fig"}). As expected, given that rabbit ZP is not involved in polyspermy blockage ([@bib30]), no polyspermy was found on embryos produced from *ZP4*-null oocytes.

As ovulation and fertilization were not affected in *ZP4*-null females, the negative effect of *ZP4* ablation can only be attributed to a developmental failure of the embryos surrounded by a ZP lacking ZP4. However, given that these Hz embryos derived from *ZP4*-disrupted oocytes were able to develop in vitro to the blastocyst stage, this developmental failure must occur in vivo. ZP protection is essential for in vivo embryo development, as rabbit embryos without zona are unable to establish pregnancy following embryo transfer ([@bib25]; [@bib36]). In vivo development was analysed in KO and WT females (three per group) crossed with fertile males and sacrificed on Day 4 post-mating. At this developmental time, rabbit embryos have developed to the blastocyst stage and are surrounded by a mucin coat, but lack ZP, which disappears between Days 3 and 4 ([@bib8]; [@bib9]). ZP dissolution does not occur in vitro as it requires both from embryo development and uterine secretions ([@bib9]). All embryos recovered from WT females at Day 4 post-mating had reached the blastocyst stage, however, less than half of the MATKO embryos recovered from KO females were able to develop to the blastocyst stage ([Figure 3A](#fig3){ref-type="fig"}). Moreover, those embryos reaching the blastocyst stage in the KO group showed a significant reduction in blastocyst expansion (\~500 vs.\~200 µm diameter for WT vs. KO, respectively, [Figure 3B](#fig3){ref-type="fig"}). ZP was absent in all WT blastocysts ([Figure 3C](#fig3){ref-type="fig"}) and in most expanded or collapsed blastocysts from the KO group, but was present in all degenerated embryos ([Figure 3D](#fig3){ref-type="fig"}), in agreement with the requirement of embryo development for ZP dissolution previously reported ([@bib9]). Evident signs of mechanical damage (non-spherical, crushed ZP) could be observed in degenerated embryos in the KO group ([Figure 3D](#fig3){ref-type="fig"}), suggesting that mechanical pressure may be at least partially responsible for the developmental failure.

![ZP4 ablation impairs blastocyst development in vivo.\
(**A**) Percentage of recovered embryos that had developed to the blastocyst stage by Day 4 post-mating. (**B**) Diameter (µm) of the blastocysts recovered on Day 4. The number of females (**A**) or blastocysts (**B**) analysed per group is indicated inside each column. In both graphs data are represented as mean ± SEM and statistical differences are based on t-test (p\<0.05). (**C**) Representative picture of Day four embryos obtained from WT females. (**D**) Representative picture of Day 4 embryos obtained from KO females. Red arrows indicate the presence of zona pellucida in some of the structures recovered and yellow letters indicate different types of structures found: Two expanded --yet smaller than those from WT females- blastocysts without zona (**B**), a collapsed blastocysts (CB) where zona was dissolved displaying a crunched appearance, a smaller expanded blastocyst retaining zona and showing also some degree of mechanical deformation (BZ), and three degenerated embryos (Deg) showing crunched zonae likely due to mechanical damage. Blastomeres (indicating several rounds of cell division before developmental arrest prior to compactation) can be easily spotted on the degenerated embryo on right.](elife-48904-fig3){#fig3}

Beyond Day 4 and before implantation, the rabbit embryo undergo a relevant embryonic growth that has not been recapitulated yet on an in vitro setting. This growth, converting a \~ 500 µm blastocyst to a \~ 3 mm expanded blastocysts from Days 4 to 6, is concomitant to the formation of a new glycoprotein matrix termed neozona and the replacement of the mucin coat by the gloiolemma ([@bib9]). To determine the carry over effects of the developmental delay observed on Day 4, in vivo development was analysed in KO and WT females (four per group) crossed with fertile males and sacrificed on Day 6 post-mating. Following post-mortem recovery, we observed that, based on the number of corpora lutea of each individual, more than half of the MATKO embryos (Hz embryos lacking ZP4 in their ZP) had been already lost by Day 6 after mating ([Figure 4A](#fig4){ref-type="fig"}), which roughly coincide with the percentage of degenerated embryos on Day 4. Furthermore, the few embryos surrounded by ZP4-null ZP present in the uterus that were not degenerated by Day 6 were developmentally arrested compared to those protected by WT ZP, as blastocyst growth was severely impaired ([Figure 4B--E](#fig4){ref-type="fig"}). These results suggest that *ZP4* confers structural properties to the ZP that are required for embryo protection during preimplantation development in vivo.

![ZP4 ablation leads to severely impaired in vivo development to expanded blastocyst.\
(**A**) Recovery rate (embryos recovered/corpora lutea) on Day 6 was significantly reduced in KO females compared with WT counterparts. (**B**) Embryo diameter by Day 6 of in vivo development was significantly inferior in the few embryos recovered from KO females compared to WT counterparts. The number of females (**A**) or blastocysts (**B**) analysed per group is indicated inside each column. In both graphs data are represented as mean ± SEM and statistical differences are based on t-test (p\<0.05). (**C**) Representative picture of Day 6 embryos recovered from a WT (left) or KO (right) female. Embryos were placed on 35 mm dishes. Yellow circles mark the location of the embryos inside the dishes. (**D--E**) Representative pictures of Day 6 embryos recovered from WT (**D**) or WT and KO (**E**) females. (**E**) 'WB' is a Day 6 blastocyst from the WT group, whereas the other structures were recovered from a KO female: KEB is an expanded blastocyst, KB a blastocyst showing a lesser degree of expansion and asterisks mark two degenerated embryos.](elife-48904-fig4){#fig4}

ZP4-devoided zona show structural abnormalities {#s2-3}
-----------------------------------------------

Morphological differences between KO and WT ZP were clearly noticeable under light microscopy: ZP lacking ZP4 appeared thinner and more irregular (less spherical) compared to WT ZP ([Figure 5A](#fig5){ref-type="fig"}). Furthermore, although a quantifiable mechanical analysis was not performed, ZP4-devoided ZP appeared easily deformable under the mechanical pressure exerted by a blunt micromanipulation needle compared to WT ZP ([Video 1](#video1){ref-type="video"}). In regard to ZP thickness, measurements by contrast light microscopy revealed a significant reduction (\~4 µm) in the absence of ZP4 to the ZP of WT or Hz females ([Figure 5A](#fig5){ref-type="fig"}). No differences in ZP thickness were noticed between WT or Hz females, suggesting that *ZP4* haploinsufficiency does not produce any obvious alteration in ZP formation, in agreement with the lack of differences in fertility between WT and Hz individuals. To further characterize the effect of *ZP4* ablation on ZP texture, we analysed WT or KO ZP from in vivo derived zygotes (\~14--15 hr post-mating) by Scanning Electron Microscopy (SEM). SEM images evidenced notable differences in textural properties between WT and ZP4 lacking ZP: while the former exhibited a smooth and compact texture, the latter displayed an uneven, rougher and porous aspect ([Figure 5B](#fig5){ref-type="fig"}). This less compact structural organization can explain its higher deformability and the larger fenestrations could lead to increased permeability. ZP permeability was tested by incubating zygotes obtained from WT or *ZP4*-null females with green fluorescent nanospheres of different diameters, ranging from 20 to 40 and 100 nm. This analysis revealed that, while 100 nm-sized nanospheres were successfully blocked by both ZPs, all 9 ZPs lacking ZP4 analyzed were permeable to 20 to 40 nm nanospheres, which are efficiently blocked by all 9 WT ZPs ([Figure 5C](#fig5){ref-type="fig"}).

![ZP4-devoided zona show structural abnormalities.\
(**A**) Representative pictures of cleaved embryos enclosed in ZP with (left) or without (right) ZP4 protein. ZP lacking ZP4 was significantly thinner than WT ZP. Hz females produced ZP overtly undistinguishable from WT counterparts. Data are represented as mean ± SEM and statistical differences are based on ANOVA (p\<0.05). (**B**) Surface Electron Microscopy (SEM) pictures of ZP with (left) or without (right) ZP4 protein. In the absence of ZP4, ZP texture looks rougher and more fenestrated. (**C**) Fluorescent nanospheres permeability test in zygotes surrounded by ZP with (upper raw) or without (lower raw) ZP4 protein. WT and KO ZP blocked 100 nm particles, as fluorescence was restricted to the outer surface of ZP in both groups (right images). In contrast, all 9 ZP4-devoided ZP analyzed were permeable to 20--40 nm nanospheres, as green fluorescence inside ZP was evident (left and central images). No green fluorescence can be observed inside WT ZP, indicating that 20--40 nm nanospheres were efficiently blocked by a ZP containing ZP4. Statistical differences based on Chi-square test (p\<0.05).](elife-48904-fig5){#fig5}

###### WT and KO ZP exhibit different behavior when mechanical pressure is exerted by a blunt micromanipulation pipette.

WT ZP (upper embryo) handles easily the pressure quickly recovering its spherical shape. In contrast, ZP4-devoided ZP (lower embryo) is easily deformable, providing a poor protection to the embryo.

10.7554/eLife.48904.010

Discussion {#s3}
==========

Despite its essential functions during folliculogenesis, fertilization and preimplantation embryo development, ZP is composed of just 3 to 4 proteins, depending on the species. Gene ablation experiments have deciphered the functions of the three proteins present in mouse ZP, but the role of the fourth component (ZP4) has remained controversial. Previous studies have suggested that ZP4 may play a role during fertilization. Rabbit ZP4 was found to bind to rabbit sperm acrosome ([@bib32]), although specific blocking by ZP4-antisera fragments could not be demonstrated. Similarly, other studies based on in vitro protein-binding assays have attributed sperm attachment to the zona matrix to ZP4 in humans ([@bib7]) or to heterocomplexes of ZP4 and ZP3 in porcine and bovine ([@bib18]; [@bib50]). In contrast with this notion, the expression of human ZP4 in transgenic mouse ZP was not sufficient to support human sperm binding ([@bib47]). In this article, we have tested ZP4 role by gene ablation in a species where it is naturally present. Although we cannot assure that ZP4 ablation might reduce sperm binding, acrosome reaction or sperm penetration in vitro, our results unequivocally show that ZP4 does not play an essential role during the fertilization process in vivo, but serves a structural and mechanical function which is fundamental to protect the developing embryo prior to implantation. In agreement with our findings, a recent study on ZP characterization hypothesized a structural role of ZP4 on increasing CP thickness in humans ([@bib27]).

ZP plays an essential protective role during preimplantation embryo development, as despite the exception of a single case report where zona-free embryos were developed in vitro up to blastocyst before transfer ([@bib37]), zona denuded embryos have been largely considered unable to complete in vivo development ([@bib6]; [@bib24]). This protective function was severely impaired following ZP4 ablation, ultimately causing embryonic death and infertility. ZP4 ablation in rabbits lead to similar structural defects in ZP to those obtained when ZP1 is ablated in mice ([@bib34]): reduction in ZP thickness and increased ZP porosity. However, the effects on fertility of *Zp1* KO were less severe than those caused by ZP4 ablation, as litter size was halved in *Zp1* KO female mice compared to WT mice, whereas ZP4 ablation abolished almost completely embryo development. A plausible explanation for this difference is that mouse embryos may demand a lesser degree of ZP protection during preimplantation development than other domestic mammals, including rabbits. The early blastocyst hatching occurring in mouse (3.5 days compared to more than 6 days in humans and most domestic mammalian species) and a reduced hydrostatic pressure in female reproductive tract motivated by its small body size may be partly responsible for this difference.

Remarkably, the laboratory mouse remain the only mammalian species studied so far where ZP4 is not present in ZP ([@bib26]), and mouse ZP is noticeably softer and more elastic compared to other mammalian ZPs containing ZP4 with or without ZP1 ([@bib48]). Further evidence for the fundamental structural role of ZP4 comes from transgenic mouse models producing humanized ZP: the expression of human ZP4 in mouse ZP was found to be able to recover the thickness and robustness lost following mouse ZP2 ablation ([@bib1]). In order to determine whether ZP4 deficiency could lead to infertility in women, we searched for loss-of-function mutations in the Genome Aggregation Database, which includes data from 141456 individuals ([@bib21]). This search revealed 48 polymorphisms in *ZP4* coding region leading to premature stop codons (PTCs), which are the most evident loss-of-function mutations ([Supplementary file 2](#supp2){ref-type="supplementary-material"} and [Figure 6](#fig6){ref-type="fig"}). The frequency of individuals carrying at least one of these PTC mutations in *ZP4* was 0.3% in the global population analysed, raising to 1% in the African dataset. Hence, in this population, roughly 1 into 40000 women would carry a PTC in both alleles, being thereby potentially infertile due to ZP4 deficiency. Mutations in ZP1-3 genes have been recently associated with women infertility ([@bib51]; [@bib27]) but the association between these PTC mutations in *ZP4* and woman infertility remains to be explored.

The evolutionary conservation of ZP4 in humans ([@bib15]; [@bib20]) and many other mammals ([@bib10]; [@bib12]; [@bib14]; [@bib16]; [@bib26]; [@bib28]; [@bib40]) points towards a conserved role of this protein. In this sense, these results highlight *ZP4* mutations as a possible cause for female infertility in both humans and livestock or wild species, and pave the way for the development of contraceptive methods based on ZP4 disruption.

![Polymorphism leading to truncated human ZP4 protein can be found at gnomAD database.\
Graphical representation of the human truncated proteins generated by the nine most frequent premature stop codon (PTCs) polymorphisms found in gnomAD database. Orange bars depicts P-type (trefoil domain), blue bars correspond to ZP domain, and red asterisks mark the position of the first amino acid affected by frame shift mutation (i.e., the end of the WT protein sequence).](elife-48904-fig6){#fig6}

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                         Designation                        Source or reference   Identifiers                                                  Additional\
  (species) or resource                                                                                                                                                       information
  ----------------------------------------------------- ---------------------------------- --------------------- ------------------------------------------------------------ -----------------------------------------------------------
  Strain, strain background (*Oryctolagus cuniculus*)   *ZP4* KO                           This article                                                                       Generated by CRISPR (M and M), available upon request.

  Antibody                                              Goat polyclonal anti-human ZP4     Santa Cruz            \#sc-49586\                                                  (1:2000)
                                                                                                                 RRID:[AB2304934](https://scicrunch.org/resolver/AB2304934)   

  Antibody                                              ImmPRESS Horse anti-goat IgG HRP   Vector Labs           \#MP-7405\                                                   (1X, ready-to-use reagent)
                                                                                                                 RRID:[AB2336526](https://scicrunch.org/resolver/AB2336526)   

  Recombinant DNA reagent                               Plasmid pMJ920                     Addgene               \#42234                                                      [@bib17]

  R ecombinant DNA reagent                              Plasmid px330                      Addgene               \#42230                                                      [@bib45]

  Sequenced-based reagent                               Primers                            This article                                                                       [Table 1](#table1){ref-type="table"} (ordered from Sigma)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animal models {#s4-1}
-------------

All animal protocols were approved by INIA Animal Welfare Committee and Madrid Region authorities (authorization PROEX040/17). Rabbits (*Oryctolagus cuniculus*, farm commercial hybrids of New Zealand White) were housed individually maintaining visual and olfactory contact with others to allow social interactions. Temperature was controlled to 20--24°C and light cycle was 14:10.

The generation of Type I genetically modified *O. cuniculus* was approved by Spanish National Biosafety Agency (authorization A/ES/17/03). *ZP4* KO were generated by CRISPR/Cas system. A single guide RNA (sgRNA) was designed at the beginning of the coding region of rabbit *ZP4* gene using MIT CRISPR design tool ([@bib45]), which also provided the five most probable off-targets. sgRNA and capped polyadenylated Cas9 mRNA were synthesized in vitro as described previously ([@bib4]). Briefly, capped polyadenylated Cas9 mRNA was produced by in vitro transcription (mMESSAGE mMACHINE T7 ULTRA kit, Life Technologies) from the plasmid pMJ920 (Addgene 42234) linearized with BstBI. sgRNA was produced by in vitro transcription (MEGAshortscript T7 kit, Life Technologies) from a PCR-amplified template using px330 vector (Addgene 42230) as previously described ([@bib45]). Cas9 mRNA and sgRNA were co-injected at 100 ng/µl and 25 ng/µl, respectively, into rabbit zygotes collected by oviductal flushing 14 hr after natural mating. Microinjected embryos were transferred one day after microinjection to the oviduct of a pseudopregnant recipient stimulated by a 0.02 mg gonadorelin IM injection (Inducel, Laboratorios Ovejero) on the previous day. Resulting pups were genotyped by clonal sequencing as previously described ([@bib4]). Genotyping was performed on both ear biopsies and blood samples in F0 generation. Following DNA purification, the genomic sequence surrounding CRISPR target site was amplified by PCR and the purified PCR product was cloned into pMD20 vector (Takara) and transformed into competent cells. 15 clones were sequenced to detect the unknown alleles (indels) generated by NHEJ-repair of CRISPR-induced DSBs on each individual. In subsequent generations, Sanger PCR sequencing was performed, as all parental alleles were already known, allowing its identification in a mixed sequencing reaction. Details of primers used for sgRNA synthesis, genotyping and off-target analysis are provided in [Table 1](#table1){ref-type="table"}.

10.7554/eLife.48904.012

###### Details of primers used for sgRNA cloning into px330 vector (*sgZP4*, target sequence in bold), PCR template generation for sgRNA synthesis (*T7sgZP4*), and genotyping of target (*GenoZP4*) and off-target sequences (*OffZP4 1--5*).

  --------------------------------------------------------------------------------------------------------------------------
  Primer       Primer sequence (5´−3´)                                          Fragment size (bp)   GenBank accession no.
  ------------ ---------------------------------------------------------------- -------------------- -----------------------
  *sgZP4*      CACCG**GTAGCACCATGTGGCTGTTA** AAACTAACAGCCACATGGTGCTACC          \-                   NC_013684.1

  *T7sgZP4*    GATCACTAATACGACTCACTATAGGG-TGCTGTCAGGGAGCTCAGTTTTAGAG-CTAGAAAT   \-                   \-

  *GenoZP4*    TGTTGCCCAACTTACCCCAG TCCCACCTGCATGCAAGAAA                        318                  NC_013684.1

  *OffZP4 1*   CAGCTGCAGTGGAAGAATGC\                                            498                  NW_003159362.1
               ACTGTAACGCAGCTTTGGGA                                                                  

  *OffZP4 2*   AACAGACACCCAGAAGCACC\                                            234                  NC_013699.1
               ACTGCCTTTTCCCACAAGCA                                                                  

  *OffZP4 3*   TCTCATCAGAGCTCCGTCCA\                                            395                  NW_003159579.1
               CTGGGAAACCACTCTCCGTC                                                                  

  *OffZP4 4*   ACAACTGTTTCAGCTAACCTCT\                                          313                  NC_013678.1
               GTTGAGTGGTCACCAAGCCT                                                                  

  *OffZP4 5*   GCCCAGGGTTAACACACAGT\                                            264                  NC_013686.1
               TCCTCTTTGACCCCTCTCCC                                                                  
  --------------------------------------------------------------------------------------------------------------------------

Immunohistochemistry {#s4-2}
--------------------

Immunohistochemistry was performed on ovaries (3/group) collected 14 hr after mating, fixed in 10% formaldehyde for 24 hr, processed and paraffin embedded. Rehydrated sections of 5 µm were incubated in 0.3% hydrogen peroxide in TBS to block endogenous peroxidase activity and then in primary antibody solution (goat polyclonal anti-human ZP4 (Santa-Cruz sc-49586) dilution 1:2000 in TBS-1% BSA solution) for 1 hr at room temperature in a moist chamber. After a brief wash in TBS, sections were incubated in secondary antibody solution (ImmPRESS horse anti-goat IgG HRP, Vector Labs MP-7405) for 30 min at 37°C and immunoreaction was revealed with 3--3´diaminobencidine. Finally, sections were counterstained with Harry´s hematoxylin (Thermo Scientific), dehydrated, cleared and mounted. Positive immunoreaction was identified as a dark-brown precipitated. The images were collected with a Leica DM 6000 microscope and Software Leica Application Suite.

Proteomics analyses {#s4-3}
-------------------

Proteomics was performed on 50 grown oocytes/group recovered by slicing ovaries in PBS. ZP was solubilized by incubation at 75°C for 45 min ([@bib16]) and analyses were carried out on one technical replicate with a HPLC/MS system consisting of an Agilent 1290 Infinity II Series HPLC (Agilent Technologies, Santa Clara, CA, USA) equipped with an Automated Multisampler module and a High Speed Binary Pump, and connected to an Agilent 6550 Q-TOF Mass Spectrometer (Agilent Technologies, Santa Clara, CA, USA) using an Agilent Jet Stream Dual electrospray (AJS-Dual ESI) interface. Experimental parameters for HPLC and Q-TOF were set in MassHunter Workstation Data Acquisition software (Agilent Technologies, Rev. B.08.00). Data processing and analysis was performed on Spectrum Mill MS Proteomics Workbench (Rev B.06.00.201, Agilent Technologies, Santa Clara, CA, USA).

Fertility analyses {#s4-4}
------------------

All experiments were performed following natural mating with WT males of proven fertility. Ovulation in rabbits is induced by mating, allowing precise determination of embryo developmental timing. Zygotes were collected post-mortem 14 hr after mating by oviductal flushing with Dulbecco´s PBS media supplemented with 1% BSA (DPBS) in five independent replicates. Ovulation rates were assessed by counting corpora lutea. Embryo culture took place on 25 µl drops of TCM-199 media (Sigma) supplemented with 5% FCS at 38.5°C in a 5% CO~2~ and 5% O~2~ water saturated atmosphere. Embryonic cleavage and development to blastocysts were assessed on Days 1 and 5 of culture, respectively.

Follicular counts were performed in histological sections of ovaries collected 14 hr after mating, fixed and stained with Haematoxylin-Eosin as detailed above (four sections per ovary, four animals per group). Pronuclear formation rates were analysed in the zygotes obtained from three females/group fixed 20 hr following mating as described previously ([@bib3]). Pronuclei were stained by incubation in 1 µM SYTOX Green (Thermofisher) for 30 min and observed under fluorescent inverted microscope (Nikon Eclipse).

To analyse in vivo development to Day 4 blastocyst, three females/group were sacrificed 4 days after mating and oviducts (where no structures were recovered) and uteri were independently flushed with DPBS. The number of structures recovered were counted and blastocysts were observed and measured under light estereomicroscopy (Zeiss V20 coupled with Hammamatsu Orca Flash 4.0 camera). A similar approach was followed to analyse in vivo development to Day 6 blastocysts, but in this case four females/group were used and only uteri were flushed. Corpora lutea and the number of structures were counted to determine recovery rates. The structures recovered were observed and measured under light estereomicroscopy (Zeiss Stemi 305 coupled with Izasa CMOS 1080P camera).

Structural analyses {#s4-5}
-------------------

Zona pellucida thickness was analysed in 30 fresh embryos/group 40--43 hr post-mating by inverted light microscopy (Nikon Eclipse) using the measurement tool of the software NIS (Nikon).

Scanning Electron Microscopy (SEM) was performed on five zygotes/group fixed in 2% glutaraldehyde for 2 hr at 4°C, washed in PBS and postfixed in 1% osmium tetroxide for 1 hr. After washing, the zygotes were dehydrated in increasing concentration of acetone and air dried. Finally, samples were sputter coated with gold and studied in Jeol-6100 scanning electron microscope.

ZP permeability test was performed by incubating fresh zygotes (3 replicates of 3 embryos/group) in 0.005% (1:1000 dilution) solutions of carboxylate-modified 505/515 Fluospheres (Invitrogen) of different sizes (20, 40 and 100 nm) for 30 min, using the culture media and atmosphere conditions detailed above. Immediately following incubation and washing, zygotes were observed under an inverted fluorescent microscope to assess the penetration of fluorescent particles. This test yields a binary result: green fluorescence can be detected inside ZP (ZP is permeable to that size of particle) or fluorescence cannot be detected inside ZP (particles do pass through ZP).

Genomic analysis {#s4-6}
----------------

Loss of function ZP4 polymorphisms passing QC filters were queried online at (<http://gnomad.broadinstitute.org/gene/ENSG00000116996>), and a cvs file was downloaded and manipulated with R v3.5.1. [Figure 6](#fig6){ref-type="fig"} was plotted taking as reference the protein sequence UniProt Q12836 and using the packages ggplot2 and drawproteins ([@bib5]), which was customized to depict frameshift mutations. Biosequence analysis using profile hidden Markov models was performed online with HMMER v1.32 ([@bib31]).

Statistical analyses {#s4-7}
--------------------

The differences between groups in litter size, ovulation and developmental rates, follicle number, in vivo embryo survival and ZP and embryo size were analysed by One-way ANOVA following Tukey´s post-hoc test or by t-test to compare 3 or two groups, respectively, except for permeability test (binary variable), where Chi-square test were used. All statistical tests were performed using the software package SigmaStat. Differences were considered statistically significant at p\<0.05.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"ZP4 confers structural properties to the zona pellucida essential for embryo development\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Michael Eisen as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Véronique Duranthon (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The zona pellucida is an essential oocyte structure for fertilization and subsequent embryonic development. Yet, the composition of this structure is species-specific, hence the difficulty to make assumptions from one animal model to the other, and to humans ultimately. ZP4 is a glycoproteic component of the zona pellucida that exists in most eutherian mammals, except the mouse. The authors report here the first ablation (CRISPR-Cas9-driven) of the Zp4 gene in rabbits and its effect on development. The zona pellucida structure appears affected in absence of ZP4, presenting as thinner and more permeable compared to wildtype. Interestingly, compared to other Zp genes, ZP4 is not absolutely required for oocyte fertilization, but has post-fertilization effects in vivo and is essential for female fertility, while being dispensable for in vitro preimplantation development.

The reviewers agreed on the fact that this is an important work, with novel conclusions and interesting implication for humans. However, there was also consensus towards the conclusion that more work is needed to properly delineate the role of ZP4 for the embryo and that some of the conclusions are not fully supported by the data..

The reviewers are well aware that obtaining edited rabbits is challenging, so between essential points 1 and 2, a choice may have to be made, regarding the limited period of 2 months that *eLife* allows for revision. Personally, I think point 2 may be the more interesting -- if equally feasible -- to experimentally address, as it may point to the reason why embryonic development fails in absence of ZP4. But wherever experiments could not be carried out, conclusions should be toned down, according to the recommendations below.

Essential revisions:

1\) The lack of effect of the ZP4 mutation on the process of fertilization is not directly proven, only implied. The authors should be more cautious in their conclusion. Additional experimental work would be needed to exclude any effect on fertilization-related events per se, like sperm binding with the egg, acrosome reaction, sperm penetration etc. There are precedents in the literature of fertilization-related proteins whose role can be masked in vivo due to compensatory mechanisms. If more edited females can be obtained, in vitro fertilization needs to be performed and sperm binding, penetration, fertilization, and polyspermy quantified under clearly-defined conditions. If it is not feasible, then the conclusion that the fertilization step is not affected should be attenuated, by limiting the conclusion to a non-oriented statement of the results = cleavage is not affected and therefore ZP4 is not absolutely required for fertilization in vivo.

2\) The discrepancy between the in vivo and in vitro developmental outcome should be better addressed. Because blastocysts were lost at Day 6 of in vivo development, the authors concluded that the main function of ZP4 is to protect the preimplantation embryo. However, this is clearly not proven. If the authors want to prove that the phenotype at Day 6 is due to preimplantation loss, further investigations are required to show when the loss occurs and establish the phenotype of that loss. Moreover, the authors fail to mention the dynamics of the rabbit zona pellucida, which disappears in vivo between Day 3 and Day 4 to be replaced by a neozona (Denker et al., 1979). Such a modification does not occur in the in vitro culture conditions used in the paper (Fisher et al., 1991). Additionally, during embryo transit in the oviduct, a mucin coat covers the developing embryo and is replaced by a gloiolemma at Day 5-6. The lack of development observed in vivo could equally result from effects of ZP4 on the formation of the mucinous coat, or, on the replacement of the zona by the neozona, none of these changes of the extracellular matrix being recapitulated in vitro. Whether ZP4 mutation may have rabbit specific effects due to these features should be discussed.

3\) About the part on human genetics of the ZP4 gene: the authors found 48 polymorphisms in ZP4 coding region leading to premature stop codons in human. They claim that ZP4 deficiencies could thus lead to infertility in human. As such, this conclusion seems overstated: only an enrichment for such mutations in infertile patients may have led to such a conclusion. This paragraph (subsection "ZP4-devoided zona show structural abnormalities", last paragraph) should be moved in the Discussion section.

4\) Statistical and quantitative analyses should be strengthened, information is often missing or incomplete.

\- mention on each graph the numbers of embryos observed in each category and not only the percentages obtained (Figure 2C, 2D, 2G, 3A, 3B, 4A).

\- Quantitative assessments on ovaries are needed to conclude that there was no effect on the development of oocytes.

\- Same for the analysis of embryonic development. For example, was there any effect on inner cell mass development?

\- Figure 2: Please mention in the legend the number of females involved. This is only mentioned in the Materials and methods section, which makes reading uneasy.

\- Only a single example of the nanosphere experiment is shown, and no quantification is reported. A quantitative, rigorous analysis is needed, with statistical tests.

\- The statistical analysis section of Materials and methods says analyses were done by ANOVA. However, ANOVA is not appropriate for only two groups (Figure 3), where a t-test should be used to compare means. ANOVA alone also cannot show comparisons among the treatment groups. A post-hoc test (e.g., Tukey\'s or Dunnet\'s) is needed. This should be specified. Also, was it confirmed that the data were normally distributed and ANOVA was appropriate? This seems unlikely for proportion data like in Figure 2.
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Author response

> Essential revisions:
>
> 1\) The lack of effect of the ZP4 mutation on the process of fertilization is not directly proven, only implied. The authors should be more cautious in their conclusion. Additional experimental work would be needed to exclude any effect on fertilization-related events per se, like sperm binding with the egg, acrosome reaction, sperm penetration etc. There are precedents in the literature of fertilization-related proteins whose role can be masked in vivo due to compensatory mechanisms. If more edited females can be obtained, in vitro fertilization needs to be performed and sperm binding, penetration, fertilization, and polyspermy quantified under clearly-defined conditions. If it is not feasible, then the conclusion that the fertilization step is not affected should be attenuated, by limiting the conclusion to a non-oriented statement of the results = cleavage is not affected and therefore ZP4 is not absolutely required for fertilization in vivo.

We apologize for not being able to provide IVF data. Rabbit sperm capacitation is difficult to achieve in vitro and, hence, rabbit IVF is particularly challenging. We routinely perform IVF in different mammalian species (bovine, mouse, sheep and pig), but to perform rabbit IVF we would need to develop a specific protocol which would not be ready to use in a reasonable time. As a result, we have toned down our conclusions by stating that these results prove that ZP4 is dispensable for fertilization in vivo (subsection "ZP4 ablation leads to severely impaired fertility" and Discussion), as similar pronuclear formation (i.e., similar monospermic sperm penetration) and embryonic cleavage (oocyte activation following sperm penetration) rates were obtained following in vivofertilization of WT and KO females (Figure 2 C, G and H).

> 2\) The discrepancy between the in vivo and in vitro developmental outcome should be better addressed. Because blastocysts were lost at Day 6 of in vivo development, the authors concluded that the main function of ZP4 is to protect the preimplantation embryo. However, this is clearly not proven. If the authors want to prove that the phenotype at Day 6 is due to preimplantation loss, further investigations are required to show when the loss occurs and establish the phenotype of that loss. Moreoever, the authors fail to mention the dynamics of the rabbit zona pellucida, which disappears in vivo between Day 3 and Day 4 to be replaced by a neozona (Denker et al., 1979). Such a modification does not occur in the in vitro culture conditions used in the paper (Fisher et al., 1991). Additionally, during embryo transit in the oviduct, a mucin coat covers the developing embryo and is replaced by a gloiolemma at Day 5-6. The lack of development observed in vivo could equally result from effects of ZP4 on the formation of the mucinous coat, or, on the replacement of the zona by the neozona, none of these changes of the extracellular matrix being recapitulated in vitro. Whether ZP4 mutation may have rabbit specific effects due to these features should be discussed.

We agree that the failure on in vivodevelopment required further characterization. To exclude any possible effect attributable to the formation of neozona or to mucin coat substitution, we have recovered embryos fertilized and developed in vivoon Day 4. At that stage the original zona pellucida has disappeared and the embryo is only surrounded by mucin coat, as neozona will be formed later (Day 5). As it can be seen in the new Figure 3, embryos derived from WT or KO females were covered by mucin and ZP was dissolved in the developing embryos surrounded by KO ZP. ZP was present in degenerated embryos as ZP dissolution requires from embryo development (Fisher et al., 1991). However despite mucin coating was normal and ZP without ZP4 could be dissolved, a clear reduction in development to blastocyst and in blastocysts size can be already noticed by that day (i.e. before mucin-gloiolemma exchange and neozona formation). Degenerated embryos and even some blastocyst trying to expand show a crunched appearance compatible with a mechanical damage occurring in the absence of ZP4. We have included a new figure with these results (Figure 3) and have modified the Results section (subsection "ZP4 ablation leads to severely impaired fertility").

> 3\) About the part on human genetics of the ZP4 gene: the authors found 48 polymorphisms in ZP4 coding region leading to premature stop codons in human. They claim that ZP4 deficiencies could thus lead to infertility in human. As such, this conclusion seems overstated: only an enrichment for such mutations in infertile patients may have led to such a conclusion. This paragraph (subsection "ZP4-devoided zona show structural abnormalities", last paragraph) should be moved in the Discussion section.

We have moved the paragraph to the Discussion section (third paragraph) and stated more clearly that we have not proved the association between the PTC mutations identified by our analysis in *ZP4* with women infertility.

> 4\) Statistical and quantitative analyses should be strengthened, information is often missing or incomplete.
>
> \- Mention on each graph the numbers of embryos observed in each category and not only the percentages obtained (Figure 2C, 2D, 2G, 3A, 3B, 4A).

We apologize for not providing earlier that information in the figures, it was included in the *eLife*´s transparent reporting form, but it will be definitely more accessible to the readers in the columns. We have now included n in all columns of the figures and detailed its meaning on figure legends.

> \- Quantitative assessments on ovaries are needed to conclude that there was no effect on the development of oocytes.

We have performed follicular counts on 4 females per group analysing 4 sections per ovary (16 sections/group). Similar numbers of antral and preantral follicles were obtained (Figure 2E-F).

> \- Same for the analysis of embryonic development. For example, was there any effect on inner cell mass development?

in vitro produced blastocysts were morphologically similar in both groups, and all blastocysts develop ICM. However, in vivodevelopment was impaired: more than half of the embryos were not able to develop to blastocyst on Day 4. Those reaching the blastocyst stage in the KO group do develop ICM, but those ICM were smaller, as the rest of the embryo. Later on development (Day 6) the developmental impairment of the KO group was more evident, but again, those embryos developing to slightly expanded blastocyst do show embryonic disc, although it was less developed than that found in the WT group (as the rest of the embryo). In other words, it seems that the damage did not affect preferentially the ICM: both TE and ICM development were reduced when ZP4 was absent from ZP.

> \- Figure 2: Please mention in the legend the number of females involved. This is only mentioned in the Materials and methods section, which makes reading uneasy.

We have added this information to the figure.

> \- Only a single example of the nanosphere experiment is shown, and no quantification is reported. A quantitative, rigorous analysis is needed, with statistical tests.

We should have provided more details for this test. This assay yields a binary result: green fluorescence detected inside ZP (permeable) or no fluorescence detected inside ZP (not permeable). All WT embryos (9) analysed following incubation with 40 or 20 nm nanospheres lacked fluorescence inside the ZP and all KO embryos (9) showed fluorescence. We have modified the subsections "ZP4-devoided zona show structural abnormalities" and "Structural analyses" to explain better this test.

> \- The statistical analysis section of Materials and methods says analyses were done by ANOVA. However, ANOVA is not appropriate for only two groups (Figure 3), where a t-test should be used to compare means. ANOVA alone also cannot show comparisons among the treatment groups. A post-hoc test (e.g., Tukey\'s or Dunnet\'s) is needed. This should be specified. Also, was it confirmed that the data were normally distributed and ANOVA was appropriate? This seems unlikely for proportion data like in Figure 2.

We have now performed t-test when 2 groups are compared. Regarding to ANOVA, the statistical software we use automatically perform ANOVA on ranks followed by Tukey´s when normalcy test fail, as it was the case for pregnancy data (Figure 2A). We have modified figure legend and Materials and methods accordingly.
